Protein-ligand interactions and drug design:
This detailed book collects modern and established computer-based methods aimed at addressing the drug discovery challenge from disparate perspectives by exploiting information on ligand-protein recognition. Beginning with methods that allow for the exploration of specific areas of chemical space an...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
New York, NY, U.S.A.
HumanaPress
[2021]
|
Schriftenreihe: | Methods in molecular biology
2266 |
Schlagworte: | |
Zusammenfassung: | This detailed book collects modern and established computer-based methods aimed at addressing the drug discovery challenge from disparate perspectives by exploiting information on ligand-protein recognition. Beginning with methods that allow for the exploration of specific areas of chemical space and the designing of virtual libraries, the volume continues with sections on methods based on docking, quantitative models, and molecular dynamics simulations, which are employed for ligand discovery or development, as well as methods exploiting an ensemble of protein structures for the identification of potential protein targets. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Protein-Ligand Interactions and Drug Design provides detailed practical procedures of solid computer-aided drug design methodologies employed to rationalize and optimize protein-ligand interactions, for experienced researchers and novices alike |
Beschreibung: | Part I: Chemical Space; ; 1. Investigation of the Click-Chemical Space for Drug Design Using ZINClick; Alberto Massarotti; ; 2. Molecular Scaffold Hopping via Holistic Molecular Representation; Francesca Grisoni and Gisbert Schneider; ; Part II: Hit Identification and Hit-to-Lead Optimization; ; 3. Biased Docking for Protein-Ligand Pose Prediction; Juan Pablo Arcon, Adrián G. Turjanski, Marcelo A. Martí, and Stefano Forli; ; 4. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking; Andrea Scarpino, György G. Ferenczy, and György M. Keseru; ; 5. Ligand-Receptor, Ligand-DNA Interactions and Drug Design; Aggeliki Syriopoulou, Ioannis Markopoulos, Andreas G. Tzakos, and Thomas Mavromoustakos; ; 6. Simulation of Ligand Transport in Receptors Using CaverDock; Jana Hozzová, Ondrej Vávra, David Bednár, and Jirí Filipovic; ; 7.Negative Image-Based Screening: Rigid Docking Using Cavity Information; Pekka A. Postila, Sami T. Kurkinen, and Olli T. Pentikäinen; ; 8. Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening; Olli T. Pentikäinen and Pekka A. Postila; ; 9. Fragment-Based Drug Design of Selective HDAC6 Inhibitors; Dusan Ruzic, Nemanja Djokovic, and Katarina Nikolic; ; 10. A Protocol to Use Comparative Binding Energy Analysis to Estimate Drug-Target Residence Time; Gaurav K. Ganotra, Ariane Nunes-Alves, and Rebecca C. Wade; ; 11. Dynamic Docking Using Multicanonical Molecular Dynamics: Simulating Complex Formation at the Atomistic Level; Gert-Jan Bekker and Narutoshi Kamiya; ; 12. Free Energy Calculations for Protein-Ligand Binding Prediction; Willem Jespers, Johan Åqvist, and Hugo Gutiérrez-de-Terán; - 13. Exploiting Water Dynamics for Pharmacophore Screening; David Schaller, Szymon Pach, Marcel Bermudez, and Gerhard Wolber; ; 14. Markov State Models to Elucidate Ligand Binding Mechanism; Yunhui Ge and Vincent A. Voelz; ; Part III: Target Identification; ; 15. From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds; Giosuè Costa, Anna Artese, Francesco Ortuso, and Stefano Alcaro; ; 16. Multiple Target Drug Design Using LigBuilder 3; Xiaoyu Qing, Shiwei Wang, Yaxia Yuan, Jianfeng Pei, and Luhua Lai; ; 17. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications; Joseph Feinstein, Wentao Shi, J. Ramanujam, and Michal Brylinski; ; 18. MDock: A Suite for Molecular Inverse Docking and Target Prediction; Zhiwei Ma and Xiaoqin Zou |
Beschreibung: | xv, 327 Seiten Illustrationen, Diagramme 254 mm |
ISBN: | 9781071612088 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV047115640 | ||
003 | DE-604 | ||
005 | 20211011 | ||
007 | t | ||
008 | 210129s2021 a||| |||| 00||| eng d | ||
020 | |a 9781071612088 |c hbk |9 978-1-0716-1208-8 | ||
024 | 3 | |a 9781071612088 | |
035 | |a (OCoLC)1249684328 | ||
035 | |a (DE-599)BVBBV047115640 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-29T |a DE-19 | ||
084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
245 | 1 | 0 | |a Protein-ligand interactions and drug design |c edited by Flavio Ballante |
264 | 1 | |a New York, NY, U.S.A. |b HumanaPress |c [2021] | |
300 | |a xv, 327 Seiten |b Illustrationen, Diagramme |c 254 mm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Methods in molecular biology |v 2266 | |
490 | 0 | |a Springer protocols | |
500 | |a Part I: Chemical Space; ; 1. Investigation of the Click-Chemical Space for Drug Design Using ZINClick; Alberto Massarotti; ; 2. Molecular Scaffold Hopping via Holistic Molecular Representation; Francesca Grisoni and Gisbert Schneider; ; Part II: Hit Identification and Hit-to-Lead Optimization; ; 3. Biased Docking for Protein-Ligand Pose Prediction; Juan Pablo Arcon, Adrián G. Turjanski, Marcelo A. Martí, and Stefano Forli; ; 4. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking; Andrea Scarpino, György G. Ferenczy, and György M. Keseru; ; 5. Ligand-Receptor, Ligand-DNA Interactions and Drug Design; Aggeliki Syriopoulou, Ioannis Markopoulos, Andreas G. Tzakos, and Thomas Mavromoustakos; ; 6. Simulation of Ligand Transport in Receptors Using CaverDock; Jana Hozzová, Ondrej Vávra, David Bednár, and Jirí Filipovic; ; 7.Negative Image-Based Screening: Rigid Docking Using Cavity Information; Pekka A. Postila, Sami T. Kurkinen, and Olli T. Pentikäinen; ; 8. Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening; Olli T. Pentikäinen and Pekka A. Postila; ; 9. Fragment-Based Drug Design of Selective HDAC6 Inhibitors; Dusan Ruzic, Nemanja Djokovic, and Katarina Nikolic; ; 10. A Protocol to Use Comparative Binding Energy Analysis to Estimate Drug-Target Residence Time; Gaurav K. Ganotra, Ariane Nunes-Alves, and Rebecca C. Wade; ; 11. Dynamic Docking Using Multicanonical Molecular Dynamics: Simulating Complex Formation at the Atomistic Level; Gert-Jan Bekker and Narutoshi Kamiya; ; 12. Free Energy Calculations for Protein-Ligand Binding Prediction; Willem Jespers, Johan Åqvist, and Hugo Gutiérrez-de-Terán; | ||
500 | |a - 13. Exploiting Water Dynamics for Pharmacophore Screening; David Schaller, Szymon Pach, Marcel Bermudez, and Gerhard Wolber; ; 14. Markov State Models to Elucidate Ligand Binding Mechanism; Yunhui Ge and Vincent A. Voelz; ; Part III: Target Identification; ; 15. From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds; Giosuè Costa, Anna Artese, Francesco Ortuso, and Stefano Alcaro; ; 16. Multiple Target Drug Design Using LigBuilder 3; Xiaoyu Qing, Shiwei Wang, Yaxia Yuan, Jianfeng Pei, and Luhua Lai; ; 17. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications; Joseph Feinstein, Wentao Shi, J. Ramanujam, and Michal Brylinski; ; 18. MDock: A Suite for Molecular Inverse Docking and Target Prediction; Zhiwei Ma and Xiaoqin Zou | ||
520 | |a This detailed book collects modern and established computer-based methods aimed at addressing the drug discovery challenge from disparate perspectives by exploiting information on ligand-protein recognition. Beginning with methods that allow for the exploration of specific areas of chemical space and the designing of virtual libraries, the volume continues with sections on methods based on docking, quantitative models, and molecular dynamics simulations, which are employed for ligand discovery or development, as well as methods exploiting an ensemble of protein structures for the identification of potential protein targets. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Protein-Ligand Interactions and Drug Design provides detailed practical procedures of solid computer-aided drug design methodologies employed to rationalize and optimize protein-ligand interactions, for experienced researchers and novices alike | ||
650 | 4 | |a Pharmaceutical technology | |
650 | 4 | |a Chemoinformatics | |
650 | 4 | |a Chemistry | |
650 | 4 | |a Chemistry, Physical and theoretical | |
650 | 4 | |a Medicine | |
653 | |a Chemische Technik | ||
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
700 | 1 | |a Ballante, Flavio |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-0716-1209-5 |
830 | 0 | |a Methods in molecular biology |v 2266 |w (DE-604)BV035362695 |9 2266 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-032522040 |
Datensatz im Suchindex
_version_ | 1804182155964710912 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Ballante, Flavio |
author2_role | edt |
author2_variant | f b fb |
author_facet | Ballante, Flavio |
building | Verbundindex |
bvnumber | BV047115640 |
classification_rvk | VS 5350 |
ctrlnum | (OCoLC)1249684328 (DE-599)BVBBV047115640 |
discipline | Chemie / Pharmazie |
discipline_str_mv | Chemie / Pharmazie |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05189nam a2200445 cb4500</leader><controlfield tag="001">BV047115640</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20211011 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210129s2021 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781071612088</subfield><subfield code="c">hbk</subfield><subfield code="9">978-1-0716-1208-8</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9781071612088</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1249684328</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047115640</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29T</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Protein-ligand interactions and drug design</subfield><subfield code="c">edited by Flavio Ballante</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY, U.S.A.</subfield><subfield code="b">HumanaPress</subfield><subfield code="c">[2021]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xv, 327 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">254 mm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Methods in molecular biology</subfield><subfield code="v">2266</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Springer protocols</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Part I: Chemical Space; ; 1. Investigation of the Click-Chemical Space for Drug Design Using ZINClick; Alberto Massarotti; ; 2. Molecular Scaffold Hopping via Holistic Molecular Representation; Francesca Grisoni and Gisbert Schneider; ; Part II: Hit Identification and Hit-to-Lead Optimization; ; 3. Biased Docking for Protein-Ligand Pose Prediction; Juan Pablo Arcon, Adrián G. Turjanski, Marcelo A. Martí, and Stefano Forli; ; 4. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking; Andrea Scarpino, György G. Ferenczy, and György M. Keseru; ; 5. Ligand-Receptor, Ligand-DNA Interactions and Drug Design; Aggeliki Syriopoulou, Ioannis Markopoulos, Andreas G. Tzakos, and Thomas Mavromoustakos; ; 6. Simulation of Ligand Transport in Receptors Using CaverDock; Jana Hozzová, Ondrej Vávra, David Bednár, and Jirí Filipovic; ; 7.Negative Image-Based Screening: Rigid Docking Using Cavity Information; Pekka A. Postila, Sami T. Kurkinen, and Olli T. Pentikäinen; ; 8. Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening; Olli T. Pentikäinen and Pekka A. Postila; ; 9. Fragment-Based Drug Design of Selective HDAC6 Inhibitors; Dusan Ruzic, Nemanja Djokovic, and Katarina Nikolic; ; 10. A Protocol to Use Comparative Binding Energy Analysis to Estimate Drug-Target Residence Time; Gaurav K. Ganotra, Ariane Nunes-Alves, and Rebecca C. Wade; ; 11. Dynamic Docking Using Multicanonical Molecular Dynamics: Simulating Complex Formation at the Atomistic Level; Gert-Jan Bekker and Narutoshi Kamiya; ; 12. Free Energy Calculations for Protein-Ligand Binding Prediction; Willem Jespers, Johan Åqvist, and Hugo Gutiérrez-de-Terán;</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - 13. Exploiting Water Dynamics for Pharmacophore Screening; David Schaller, Szymon Pach, Marcel Bermudez, and Gerhard Wolber; ; 14. Markov State Models to Elucidate Ligand Binding Mechanism; Yunhui Ge and Vincent A. Voelz; ; Part III: Target Identification; ; 15. From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds; Giosuè Costa, Anna Artese, Francesco Ortuso, and Stefano Alcaro; ; 16. Multiple Target Drug Design Using LigBuilder 3; Xiaoyu Qing, Shiwei Wang, Yaxia Yuan, Jianfeng Pei, and Luhua Lai; ; 17. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications; Joseph Feinstein, Wentao Shi, J. Ramanujam, and Michal Brylinski; ; 18. MDock: A Suite for Molecular Inverse Docking and Target Prediction; Zhiwei Ma and Xiaoqin Zou</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This detailed book collects modern and established computer-based methods aimed at addressing the drug discovery challenge from disparate perspectives by exploiting information on ligand-protein recognition. Beginning with methods that allow for the exploration of specific areas of chemical space and the designing of virtual libraries, the volume continues with sections on methods based on docking, quantitative models, and molecular dynamics simulations, which are employed for ligand discovery or development, as well as methods exploiting an ensemble of protein structures for the identification of potential protein targets. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Protein-Ligand Interactions and Drug Design provides detailed practical procedures of solid computer-aided drug design methodologies employed to rationalize and optimize protein-ligand interactions, for experienced researchers and novices alike</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemoinformatics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Physical and theoretical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Chemische Technik</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ballante, Flavio</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-0716-1209-5</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Methods in molecular biology</subfield><subfield code="v">2266</subfield><subfield code="w">(DE-604)BV035362695</subfield><subfield code="9">2266</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032522040</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV047115640 |
illustrated | Illustrated |
index_date | 2024-07-03T16:27:24Z |
indexdate | 2024-07-10T09:03:04Z |
institution | BVB |
isbn | 9781071612088 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032522040 |
oclc_num | 1249684328 |
open_access_boolean | |
owner | DE-29T DE-19 DE-BY-UBM |
owner_facet | DE-29T DE-19 DE-BY-UBM |
physical | xv, 327 Seiten Illustrationen, Diagramme 254 mm |
publishDate | 2021 |
publishDateSearch | 2021 |
publishDateSort | 2021 |
publisher | HumanaPress |
record_format | marc |
series | Methods in molecular biology |
series2 | Methods in molecular biology Springer protocols |
spelling | Protein-ligand interactions and drug design edited by Flavio Ballante New York, NY, U.S.A. HumanaPress [2021] xv, 327 Seiten Illustrationen, Diagramme 254 mm txt rdacontent n rdamedia nc rdacarrier Methods in molecular biology 2266 Springer protocols Part I: Chemical Space; ; 1. Investigation of the Click-Chemical Space for Drug Design Using ZINClick; Alberto Massarotti; ; 2. Molecular Scaffold Hopping via Holistic Molecular Representation; Francesca Grisoni and Gisbert Schneider; ; Part II: Hit Identification and Hit-to-Lead Optimization; ; 3. Biased Docking for Protein-Ligand Pose Prediction; Juan Pablo Arcon, Adrián G. Turjanski, Marcelo A. Martí, and Stefano Forli; ; 4. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking; Andrea Scarpino, György G. Ferenczy, and György M. Keseru; ; 5. Ligand-Receptor, Ligand-DNA Interactions and Drug Design; Aggeliki Syriopoulou, Ioannis Markopoulos, Andreas G. Tzakos, and Thomas Mavromoustakos; ; 6. Simulation of Ligand Transport in Receptors Using CaverDock; Jana Hozzová, Ondrej Vávra, David Bednár, and Jirí Filipovic; ; 7.Negative Image-Based Screening: Rigid Docking Using Cavity Information; Pekka A. Postila, Sami T. Kurkinen, and Olli T. Pentikäinen; ; 8. Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening; Olli T. Pentikäinen and Pekka A. Postila; ; 9. Fragment-Based Drug Design of Selective HDAC6 Inhibitors; Dusan Ruzic, Nemanja Djokovic, and Katarina Nikolic; ; 10. A Protocol to Use Comparative Binding Energy Analysis to Estimate Drug-Target Residence Time; Gaurav K. Ganotra, Ariane Nunes-Alves, and Rebecca C. Wade; ; 11. Dynamic Docking Using Multicanonical Molecular Dynamics: Simulating Complex Formation at the Atomistic Level; Gert-Jan Bekker and Narutoshi Kamiya; ; 12. Free Energy Calculations for Protein-Ligand Binding Prediction; Willem Jespers, Johan Åqvist, and Hugo Gutiérrez-de-Terán; - 13. Exploiting Water Dynamics for Pharmacophore Screening; David Schaller, Szymon Pach, Marcel Bermudez, and Gerhard Wolber; ; 14. Markov State Models to Elucidate Ligand Binding Mechanism; Yunhui Ge and Vincent A. Voelz; ; Part III: Target Identification; ; 15. From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds; Giosuè Costa, Anna Artese, Francesco Ortuso, and Stefano Alcaro; ; 16. Multiple Target Drug Design Using LigBuilder 3; Xiaoyu Qing, Shiwei Wang, Yaxia Yuan, Jianfeng Pei, and Luhua Lai; ; 17. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications; Joseph Feinstein, Wentao Shi, J. Ramanujam, and Michal Brylinski; ; 18. MDock: A Suite for Molecular Inverse Docking and Target Prediction; Zhiwei Ma and Xiaoqin Zou This detailed book collects modern and established computer-based methods aimed at addressing the drug discovery challenge from disparate perspectives by exploiting information on ligand-protein recognition. Beginning with methods that allow for the exploration of specific areas of chemical space and the designing of virtual libraries, the volume continues with sections on methods based on docking, quantitative models, and molecular dynamics simulations, which are employed for ligand discovery or development, as well as methods exploiting an ensemble of protein structures for the identification of potential protein targets. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Protein-Ligand Interactions and Drug Design provides detailed practical procedures of solid computer-aided drug design methodologies employed to rationalize and optimize protein-ligand interactions, for experienced researchers and novices alike Pharmaceutical technology Chemoinformatics Chemistry Chemistry, Physical and theoretical Medicine Chemische Technik (DE-588)4143413-4 Aufsatzsammlung gnd-content Ballante, Flavio edt Erscheint auch als Online-Ausgabe 978-1-0716-1209-5 Methods in molecular biology 2266 (DE-604)BV035362695 2266 |
spellingShingle | Protein-ligand interactions and drug design Methods in molecular biology Pharmaceutical technology Chemoinformatics Chemistry Chemistry, Physical and theoretical Medicine |
subject_GND | (DE-588)4143413-4 |
title | Protein-ligand interactions and drug design |
title_auth | Protein-ligand interactions and drug design |
title_exact_search | Protein-ligand interactions and drug design |
title_exact_search_txtP | Protein-ligand interactions and drug design |
title_full | Protein-ligand interactions and drug design edited by Flavio Ballante |
title_fullStr | Protein-ligand interactions and drug design edited by Flavio Ballante |
title_full_unstemmed | Protein-ligand interactions and drug design edited by Flavio Ballante |
title_short | Protein-ligand interactions and drug design |
title_sort | protein ligand interactions and drug design |
topic | Pharmaceutical technology Chemoinformatics Chemistry Chemistry, Physical and theoretical Medicine |
topic_facet | Pharmaceutical technology Chemoinformatics Chemistry Chemistry, Physical and theoretical Medicine Aufsatzsammlung |
volume_link | (DE-604)BV035362695 |
work_keys_str_mv | AT ballanteflavio proteinligandinteractionsanddrugdesign |